Earnings Unscripted: Stock Earnings Calls & Analysis
Canopy Growth's Q4 2026 revealed that capturing Canada's top medical market spot came with a brutal, immediate profitability hangover. In ~10 minutes ⏱️: • The $10.7M inventory purge triggered by the MTL Cannabis acquisition. • Why the Storz & Bickel vaporizer division took a $61M impairment. • How VA reimbursement cuts forced an immediate rewrite of pricing strategies. • Closing the Kelowna cultivation facility to centralize output and cut costs. • Management's explicit warning for slower revenue growth in H1 2027. Despite shedding physical assets and pivoting away from ultra-premium vaporizers, Canopy exited the quarter with a strong $131 million net cash position. The post-earnings market reaction was entirely flat as investors weigh the short-term pain of restructuring against management's promise of adjusted EBITDA profitability next year. Canopy Growth Corporation (CGC) | Q4 FY2026 AI-assisted production. Feedback/ticker requests: https://x.com/EarnUnscripted.
381 episodios
Comentarios
0Sé la primera persona en comentar
¡Regístrate ahora y únete a la comunidad de Earnings Unscripted: Stock Earnings Calls & Analysis!